Locus Cell Co (ROCO:06891) Debt-to-Asset : 0.04 (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Locus Cell Co Debt-to-Asset?

Locus Cell Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was NT$11.62 Mil. Locus Cell Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was NT$59.38 Mil. Locus Cell Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2024 was NT$1,926.41 Mil. Locus Cell Co's debt to asset for the quarter that ended in Jun. 2024 was 0.04.

Locus Cell Co Debt-to-Asset Historical Data

The historical data trend for Locus Cell Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Locus Cell Co Debt-to-Asset Chart

Locus Cell Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

0.03

0.04

Locus Cell Co Quarterly Data
	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Debt-to-Asset	Get a 7-Day Free Trial								0.04	0.04	0.04	0.04	0.04

Competitive Comparison of Locus Cell Co's Debt-to-Asset

For the Biotechnology subindustry, Locus Cell Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Locus Cell Co's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Locus Cell Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Locus Cell Co's Debt-to-Asset falls into.

Locus Cell Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Locus Cell Co's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(14.274	+	62.583)	/	1915.337
	=	0.04

Locus Cell Co's Debt-to-Asset for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(11.622	+	59.376)	/	1926.411
	=	0.04

Locus Cell Co (ROCO:06891) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Locus Cell Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Locus Cell Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Locus Cell Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Locus Cell Co Ltd (ROCO:06891) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Xintai 5th Road, 19th FLoor.-12, No.97, Section 1, Xizhi District, New Taipei, TWN

Website

http://www.locus-cell.com

Locus Cell Co Ltd focuses on contract development and manufacturing services for cell therapy-related products.

Locus Cell Co Headlines

No Headlines